Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPS6018659B2 - Novel benzofuran derivative - Google Patents
[go: Go Back, main page]

JPS6018659B2 - Novel benzofuran derivative - Google Patents

Novel benzofuran derivative

Info

Publication number
JPS6018659B2
JPS6018659B2 JP13876A JP13876A JPS6018659B2 JP S6018659 B2 JPS6018659 B2 JP S6018659B2 JP 13876 A JP13876 A JP 13876A JP 13876 A JP13876 A JP 13876A JP S6018659 B2 JPS6018659 B2 JP S6018659B2
Authority
JP
Japan
Prior art keywords
methyl
acid
group
reaction
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP13876A
Other languages
Japanese (ja)
Other versions
JPS5283543A (en
Inventor
重多賀 吉名
勉 亀山
由昌 生地
晃 清原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Priority to JP13876A priority Critical patent/JPS6018659B2/en
Publication of JPS5283543A publication Critical patent/JPS5283543A/en
Publication of JPS6018659B2 publication Critical patent/JPS6018659B2/en
Expired legal-status Critical Current

Links

Landscapes

  • Furan Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

【発明の詳細な説明】 本発明は一般式〔1〕 〔式中R,はC2〜C6のアルキル基、C,〜C6のア
ルコキシ基、C3〜C6のシクロアルキル基、C3〜C
6のシクロアルコキシ基、C3〜C4のアルケニル基、
C3〜C4のアルケニルオキシ基、シクロヘキセニル基
、シクロヘキセニルオキシ基、フェニル基、一般式〔0
〕で表わされる層 換フェニル基(式中R2は、メチル、エチル、ィソプロ
ピル等の低級アルキル基、ハロゲン原子、メトキシ基の
いずれかを意味する)、フェノキシ基、臭素、弗素原子
、トリフルオロメチル基、べンジル基、一般式〔m〕表
わされる置換ペンジル基(式中R2は前記(2}式と同
意味を示す)のいずれかを意味する〕で表わされる新規
なべンゾフラン誘導体である5−置換−3ーメチル−2
ーベンゾフリル酢酸およびその薬理的に無毒な塩に関す
る。
Detailed Description of the Invention The present invention is based on the general formula [1] [wherein R is a C2-C6 alkyl group, a C,-C6 alkoxy group, a C3-C6 cycloalkyl group, a C3-C6
6 cycloalkoxy group, C3-C4 alkenyl group,
C3-C4 alkenyloxy group, cyclohexenyl group, cyclohexenyloxy group, phenyl group, general formula [0
] A layered phenyl group (in the formula, R2 means a lower alkyl group such as methyl, ethyl, isopropyl, etc., a halogen atom, or a methoxy group), a phenoxy group, a bromine atom, a fluorine atom, a trifluoromethyl group , a benzyl group, a substituted penzyl group represented by the general formula [m] (wherein R2 means any of the same meanings as in the above formula (2))], which is a 5-substituted novel benzofuran derivative. -3-methyl-2
-Relating to benzofuryl acetic acid and its pharmacologically non-toxic salts.

上記一般式〔1〕で表わされる本願の目的化合物は鎮痛
作用および消炎作用を有し医薬として使用される。
The object compound of the present application represented by the above general formula [1] has analgesic and anti-inflammatory effects and is used as a medicine.

従釆、消炎鎮痛剤としては大別してステロイド剤と非ス
テロイド剤が知られている。
Anti-inflammatory analgesics are broadly classified into steroids and non-steroids.

これらは製剤にもよるが、いずれも副作用が認められる
。特にステロイド剤は長期使用によって副作用が増す。
従って副作用のより少ない優れた非ステロイド性の消炎
鎮痛剤が望まれている。
Although it depends on the formulation, all of them have side effects. In particular, long-term use of steroids increases the side effects.
Therefore, an excellent non-steroidal anti-inflammatory analgesic agent with fewer side effects is desired.

本発明者らは、非ステロイド系の化合物を種々合成し、
その薬理効果を検索した結果、一般式〔1〕で表わされ
る化合物が副作用が弱く優れた消炎鎮痛作用を有するこ
とを見し、出し、本願発明を完成するに至ったものであ
る。
The present inventors synthesized various non-steroidal compounds,
As a result of searching for its pharmacological effects, it was found that the compound represented by the general formula [1] has weak side effects and excellent anti-inflammatory and analgesic effects, which led to the completion of the present invention.

本発明の目的化合物は、たとえば次のA〜Eのような方
法で合成される。
The target compound of the present invention is synthesized, for example, by the following methods A to E.

A 5−置換−3−メチル−2−シアノメチルベンゾフ
ランを出発原料とする方法。
A method using 5-substituted-3-methyl-2-cyanomethylbenzofuran as a starting material.

一般式〔N〕 (式中R,は前記と同意義を有する)で表わされる5−
置換−3−メチル−2−シァノメチルベンゾフラン(ド
イツ特許1203277に記載の方法で得られる)を含
水溶媒中、酸またはアルカリの存在下で必要ならば加熱
して加水分解する。
5- represented by the general formula [N] (wherein R has the same meaning as above)
Substituted-3-methyl-2-cyanomethylbenzofurans (obtained by the method described in German patent 1203277) are hydrolyzed in an aqueous solvent in the presence of an acid or alkali, if necessary with heating.

ここで使う酸としては、無機、有機の酸、たとえば塩酸
、硫酸、リン酸、パラトルェンスルホン酸などがあげら
れる。また強酸性イオン交換樹脂もまた同じ目的にに使
用しうる。またここで使うアルカリとしては、アルカリ
金属、アルカリ士類金属の水酸化物、たとえば水酸化ナ
トリウム、水酸化カリウム、水酸化カルシウムなどがあ
げられる。
Examples of acids used here include inorganic and organic acids, such as hydrochloric acid, sulfuric acid, phosphoric acid, and paratoluenesulfonic acid. Strongly acidic ion exchange resins can also be used for the same purpose. Examples of the alkali used here include hydroxides of alkali metals and alkali metals, such as sodium hydroxide, potassium hydroxide, and calcium hydroxide.

溶媒としては、反応に関与しない有機溶媒と水とを併用
する。反応に関与しない有機溶媒としてはたとえばメタ
ノール、エタノール、nープロ/ぐノ一ル、イソプロパ
ノール、企rt−ブタノールなどの低級アルコール、ジ
オキサン、テトラヒドロフラン、アセトン、2−メトキ
シエタノール、2ーエトキシェタノールなどがあげられ
る。通常水と有機溶媒は水1客に対し、有機溶媒1/4
客から4客の割合で用いられる。反応温度は溶媒系の沸
点が好ましく、通常50〜100qoで行なわれる。目
的化合物の単離は、次の如く行なわれる。
As the solvent, an organic solvent that does not participate in the reaction and water are used in combination. Examples of organic solvents that do not participate in the reaction include lower alcohols such as methanol, ethanol, n-pro/gnol, isopropanol, and rt-butanol, dioxane, tetrahydrofuran, acetone, 2-methoxyethanol, and 2-ethoxycetanol. can give. Normally, water and organic solvent are 1/4 part of organic solvent for 1 part of water.
It is used at a ratio of 4 to 4 customers. The reaction temperature is preferably the boiling point of the solvent system, and is usually carried out at 50 to 100 qo. Isolation of the target compound is carried out as follows.

即ち、加水分した反応液を必要ならば活性炭処理を行な
った後、必要ならば濃縮し反応液を酸で(たとえば塩酸
、硫酸などが用いられる)酸性にして、次いで冷却し、
晶出せしめる。さらに必要ならばこの粗結晶を適当な溶
媒系、たとえば含水アルコールなどから再結晶する。B
5一置換−3ーメチル−2‐アセチルベンゾフランを
出発原料とする方法。
That is, after the hydrolyzed reaction solution is treated with activated carbon if necessary, it is concentrated if necessary, the reaction solution is acidified with an acid (for example, hydrochloric acid, sulfuric acid, etc. are used), and then cooled.
Let it crystallize. Furthermore, if necessary, the crude crystals are recrystallized from a suitable solvent system, such as hydrous alcohol. B
5 A method using monosubstituted-3-methyl-2-acetylbenzofuran as a starting material.

一般式〔V〕 (式中R,は前記と同意義を有す)で表わされる5一置
換−3−メチル−2一アセチルベンゾフラン〔ビルトア
ン・ドウ・ラ・ソシエテ・シミツク・ドウ・フランス(
B山1.Soc.Chim.Fr.)1970(10)
、3601頁に記載の方法によって得られる〕を水溶液
中、あるし、は含水有機溶媒溶液中、硫化水素あるいは
硫黄の1種およびアンモニア、第一および第二ァミンの
1種と反応させ一般式〔V〕で表わされる化合物のチオ
アミドを合成する。
5-monosubstituted-3-methyl-2-acetylbenzofuran represented by the general formula [V] (wherein R has the same meaning as above)
Mountain B 1. Soc. Chim. Fr. )1970(10)
, page 3601] is reacted with hydrogen sulfide or one of sulfur and one of ammonia, primary and secondary amines in an aqueous solution or in a water-containing organic solvent solution. A thioamide of a compound represented by V] is synthesized.

この時使用される代表的なアミンとしては、メチルアミ
ン、ジメチルアミン、ピベリジン、モルホリンなどがあ
げられる。また、反応に用いられる有機溶媒としてはジ
オキサン、ピベリジンなどが好ましく、場合により反応
に使用されるアミンが溶媒を兼ねることもできる。
Typical amines used at this time include methylamine, dimethylamine, piperidine, and morpholine. Further, as the organic solvent used in the reaction, dioxane, piverizine, etc. are preferable, and in some cases, the amine used in the reaction can also serve as a solvent.

反応温度は130〜20000で、反応時間は5〜25
時間が好ましい。
The reaction temperature is 130-20000, and the reaction time is 5-25
time is preferable.

反応後「反応液を冷却するとチオアミドの結晶が析出す
るが、より収率よくチオアミドを得るためには、反応液
を濃縮して溶媒を留去し、水を加えると収率よくチオア
ミドが得られる。得られたチオアミドを酸あるいはアル
カリで加水分解すると一般式〔1〕で表わされる5一贋
換−3−メチル−ペンゾフリル酢酸が得られる。
After the reaction, thioamide crystals precipitate when the reaction solution is cooled, but in order to obtain thioamide with a higher yield, concentrate the reaction solution, distill off the solvent, and add water to obtain thioamide with a higher yield. When the obtained thioamide is hydrolyzed with acid or alkali, 5-mono-3-methyl-penzofuryl acetic acid represented by the general formula [1] is obtained.

ここで使用される酸としては無機、有機の酸たたとえば
塩酸、硫酸、パラトルェンスルホン酸などがアルカリと
してはアルカリ金属、アルカリ士類金属の水酸化物たと
えば水酸化ナトリウム、水酸化カリウムなどがあげられ
る。目的化合物の単離は次の如く行なわれる。即ち、加
水分解して得られた目的物を含む反応液を希アルカリ、
たとえば炭酸ソーダなどで中和後、適当な有機溶媒(た
とえばベンゼンなど)で洗浄し、ついで水層を希酸たと
えば希塩酸、希硫酸などで酸性にして、目的の酸を遊離
させ、これを有機溶媒、たとえば酢酸エチルなどで、抽
出し、有機溶媒層を脱水後、濃縮し適当な溶媒系、たと
えば含水メタノール、エタノールなどから再結晶する。
C 2−ハロメチル−3−メチル−5−置換ペンゾフラ
ンを出発原料とする方法。
The acids used here include inorganic and organic acids such as hydrochloric acid, sulfuric acid, para-toluene sulfonic acid, etc. The alkalis used include hydroxides of alkali metals and alkali metals such as sodium hydroxide, potassium hydroxide, etc. can give. Isolation of the target compound is carried out as follows. That is, a reaction solution containing the target product obtained by hydrolysis is mixed with a dilute alkali,
For example, after neutralizing with soda carbonate, etc., washing with a suitable organic solvent (such as benzene), the aqueous layer is made acidic with a dilute acid such as dilute hydrochloric acid or dilute sulfuric acid to liberate the desired acid, and this is converted into an organic solvent. , for example, with ethyl acetate, and the organic solvent layer is dehydrated, concentrated, and recrystallized from a suitable solvent system, such as aqueous methanol, ethanol, etc.
A method using C2-halomethyl-3-methyl-5-substituted penzofuran as a starting material.

新鮮な金属表面をもつた削り状、細粒状、粉末状あるい
はリボン状の金属マグネシウムを適当な溶媒、たとえば
エーテル類(例えば低級アルキルエーテル、あるいはテ
トラヒドロフランなど)、第三アミン類(例えばジメチ
ルアニリンなど)、あるいは芳香族炭化水素(例えばベ
ンゼン、トルェン、キシレンなど)に懸濁させ、必要な
らばヨードの結晶を添加して、マグネシウム懸濁液を作
る。
Magnesium metal in the form of shavings, fine particles, powder or ribbons with a fresh metal surface is dissolved in a suitable solvent such as ethers (such as lower alkyl ethers or tetrahydrofuran) or tertiary amines (such as dimethylaniline). or by suspending it in an aromatic hydrocarbon (eg benzene, toluene, xylene, etc.) and adding iodine crystals if necessary to form a magnesium suspension.

一般式〔W〕 式中R,は前記と同意義を有し、×は塩素原子あるいは
臭素原子を意味する)で表わされる2−ハロメチル−3
−メチル−5‐置換ペンゾフラン(ドイツ特許第120
3277に記載の方法によって得られる)をマグネシウ
ムの懸濁に使ったと同じ溶媒に溶解して得た溶液を上で
得られたマグネシウム懸濁液に滴下し、加熱還流させて
グリニア試薬を生成させる。
General formula [W] 2-halomethyl-3 represented by (R, in the formula has the same meaning as above, and x means a chlorine atom or a bromine atom)
-Methyl-5-substituted penzofurans (German Patent No. 120)
3277) in the same solvent used to suspend magnesium is added dropwise to the magnesium suspension obtained above and heated to reflux to produce a Grignard reagent.

この時のマグネシウムの量は原料化合物に対し等モルか
ら0.1モル程度過剰が適当である。マグネシウム懸濁
液の溶媒量は少なくともマグネシウムを覆う程度の量ま
たは2〜3倍客あればよい。原料化合物の溶液の濃度は
特に限定はないが、30〜5匹重量%がこのましい。添
加するヨードの作用機序は明らかではないが、マグネシ
ウムの活性化剤として効果がある。次に得られたグリニ
ア試薬溶液を冷却後これに炭酸ガスを吹込むことにより
、あるいはグリニア試薬溶液を固体炭酸ガス上に注ぐこ
とにより炭酸付加物を生成させる。
At this time, the appropriate amount of magnesium is approximately equimolar to 0.1 molar excess relative to the raw material compound. The amount of solvent in the magnesium suspension should be at least enough to cover the magnesium, or 2 to 3 times as much. The concentration of the solution of the raw material compound is not particularly limited, but is preferably 30 to 5% by weight. Although the mechanism of action of added iodine is not clear, it is effective as a magnesium activator. Next, a carbonic acid adduct is produced by blowing carbon dioxide gas into the resulting Grignard reagent solution after cooling it, or by pouring the Grignard reagent solution onto solid carbon dioxide gas.

この反応は比較的低温、例えば一15午0〜10℃好ま
しくは−5℃〜0℃で行なわれる。反応に使用する炭酸
ガスの量はグリニア試薬の5〜10倍モルが好適である
。生成した炭酸付加物を常法により、たとえば希鉱酸で
加水分解すると目的物の5−置換−3ーメチルー2−ペ
ンゾフリル酢酸が生成する。
This reaction is carried out at a relatively low temperature, for example between 0 and 10°C, preferably between -5°C and 0°C. The amount of carbon dioxide gas used in the reaction is preferably 5 to 10 times the amount of the Grignard reagent. When the produced carbonic acid adduct is hydrolyzed by a conventional method, for example, with a dilute mineral acid, the target product, 5-substituted-3-methyl-2-penzofuryl acetic acid, is produced.

反応生成物から目的物の単離は次の如く行なわれる。即
ち反応生成物を有機溶媒たとえばエーテル、ククロロホ
ルム、酢酸エチルなどで抽出し、その有機層を希アルカ
リたとえば炭酸ソーダなどの水溶液で抽出し、更に希酸
たとえば希塩酸、希硫酸などで酸性とし遊離した目的の
酸を有機溶媒たとえば酢酸エチルなどで抽出し、得られ
た溶液を脱水後、濃縮し適当な溶媒系例えば含水メタノ
ール、エタノールなどから再結晶する。D 5−置換−
3ーメチル−2−ペンゾフロィルァゾメタンを出発原料
とする方法。
The target product is isolated from the reaction product as follows. That is, the reaction product is extracted with an organic solvent such as ether, dichloroform, or ethyl acetate, and the organic layer is extracted with an aqueous solution of a dilute alkali such as sodium carbonate, and then acidified with a dilute acid such as dilute hydrochloric acid or dilute sulfuric acid to liberate it. The desired acid is extracted with an organic solvent such as ethyl acetate, and the resulting solution is dehydrated, concentrated, and recrystallized from a suitable solvent system such as aqueous methanol, ethanol, etc. D 5-substitution-
A method using 3-methyl-2-penzofuroylazomethane as a starting material.

一般式〔W〕 (式中R,は前記と同意義を有する)で表わされる5‐
置換‐3−メチル‐2−ペンゾフロィルジアゾメタン〔
KhimiyaGeterotsiklicheski
khSMdinenii.1973(5)、579頁、
(ソ連)に記載の方法によって得られる〕を、水の存在
下でゥオルフ転位を行って一般式〔1〕で表わされる本
願目的化合物を得る。
5- represented by the general formula [W] (wherein R has the same meaning as above)
Substituted-3-methyl-2-penzophyldiazomethane [
Khimiya Geterotsiklicheski
khSMdinenii. 1973(5), page 579,
(obtained by the method described in USSR)] is subjected to Wolff rearrangement in the presence of water to obtain the object compound of the present invention represented by the general formula [1].

ウオルフ転位に使用する触媒としては酸化銀、酸化鋼、
酸化白金、チオ硫酸ナトリウム、安息香酸銀のトリェチ
ルアミン溶液、水酸化ナトリウム、水酸化カリウムの水
−エタノール混合溶液などを用いることができる。ここ
で用いられる溶媒としては反応に関与しないものであれ
ば特に限定はないが〜たとえばジオキサン、テトラヒド
ロフランなどがあげられる。反応温度は室温でよいが必
要に応じて加熱してもよい。目的化合物の単離は次の如
くに行なわれる。
Catalysts used for Wolff rearrangement include silver oxide, oxidized steel,
Platinum oxide, sodium thiosulfate, a triethylamine solution of silver benzoate, a water-ethanol mixed solution of sodium hydroxide, potassium hydroxide, etc. can be used. The solvent used here is not particularly limited as long as it does not participate in the reaction; examples thereof include dioxane, tetrahydrofuran, and the like. The reaction temperature may be room temperature, but may be heated if necessary. Isolation of the target compound is carried out as follows.

即ち反応終了後、必要ならば反応液に活性炭を加えて脱
色炉過し、ついで炉液に適当な鉱酸、有機酸たとえば塩
酸、硫酸、酢酸などを加えて酸性にして目的の酸を遊離
、折出せしめる。この粗結晶を適当な溶媒系たとえば含
水メタノール、エタノールなどから再結晶する。E 4
−〔(5一層襖−3−メチル−2−ペンゾフリル)メチ
ル〕一2H−1,3,5ーオキサジアジンー2−オンを
出発原料とする方法。
That is, after the completion of the reaction, if necessary, activated carbon is added to the reaction solution and it is passed through a decolorizing oven, and then a suitable mineral acid or organic acid such as hydrochloric acid, sulfuric acid, acetic acid, etc. is added to the oven solution to acidify it and liberate the desired acid. Let it come out. The crude crystals are recrystallized from a suitable solvent system such as aqueous methanol or ethanol. E 4
- A method using [(5-layer fusuma-3-methyl-2-penzofuryl)methyl]-2H-1,3,5-oxadiazin-2-one as a starting material.

一般式〔肌〕(式中R,は前記と同意義を有する)で表
わされる4‐〔(5‐置換−3−メチル‐2ーベンゾフ
リル)メチル〕−が‐1,3,5−オキサジアジンー2
ーオン〔たとえばインデイアン・ジヤーナル・オブ・ケ
ミストリー2(11)、459〜60頁、1964王に
記載の方法に準じて得られる〕を酢酸、エタノール、ジ
オキサン、ベンゼン等の有機溶媒中、塩酸、硫酸などの
雛酸、p−トルェンスルホン酸などの有機酸の存在下煮
沸し、反応後濃縮冷却し、5−置換−3−メチル−2−
ペンゾフリル酢酸の粗結晶を得る。
4-[(5-substituted-3-methyl-2-benzofuryl)methyl]- represented by the general formula [skin] (in the formula, R has the same meaning as above) is -1,3,5-oxadiazine-2
-one [obtained, for example, according to the method described in Indian Journal of Chemistry 2 (11), pp. 459-60, 1964] in an organic solvent such as acetic acid, ethanol, dioxane, benzene, etc., hydrochloric acid, sulfuric acid, etc. Boiled in the presence of an organic acid such as hinaic acid or p-toluenesulfonic acid, and after the reaction, concentrated and cooled to give 5-substituted-3-methyl-2-
Crude crystals of benzofuryl acetic acid are obtained.

目的化合物の単離、精製は反応液より炉取される粗結晶
をメタノールなどの適当な溶媒で再結晶して行なわれる
。以上の如く、例えばA〜Eの如き方法で合成された一
般式〔1〕で表わされる5−置換−3ーメチル−2−ペ
ンゾフリル酢酸は必要に応じてたとえばナトリウム、カ
リウム、カルシウム、アルミニウム、アンモニアおよび
ジエチルアミンやトリェタノールアミンなどのアミンな
どの塩とすることができる。
The target compound is isolated and purified by recrystallizing the crude crystals collected from the reaction solution using a suitable solvent such as methanol. As mentioned above, the 5-substituted-3-methyl-2-benzofuryl acetic acid represented by the general formula [1] synthesized by the methods A to E may contain sodium, potassium, calcium, aluminum, ammonia, etc. as necessary. It can be a salt of an amine such as diethylamine or triethanolamine.

これら塩の製造は一般式〔1〕で表わされる化合物とア
ンモニア、アミンなどの有機塩基、および金属酸化物ま
たは金属水酸化物物などの無機塩基とを反応させる一般
的公知方法によって製造することができる。以上の如く
合成された本発明の目的化合物及び薬理的に無毒な塩類
は消炎作用および鎮痛作用を有し消炎剤および鎮痛剤と
して使用される。
These salts can be produced by a generally known method of reacting the compound represented by the general formula [1] with an organic base such as ammonia or amine, and an inorganic base such as a metal oxide or metal hydroxide. can. The object compound of the present invention and pharmacologically non-toxic salts synthesized as described above have anti-inflammatory and analgesic effects and are used as anti-inflammatory and analgesic agents.

その例を以下試験法と共に第1表に、例示する。対照薬
物として非ステロイド系消炎剤ィブプロフェン(比up
rofen)を用いた。試験法 A ラツト後肢でのカラゲニン浮腫に対する抗浮腫作用
:山崎らの方法〔日本薬理学雑誌63巻、302頁(1
967)参照〕に準じて抗浮腫作用を観察した。
Examples thereof are shown in Table 1 below along with the test methods. The non-steroidal anti-inflammatory drug ibuprofen (up
rofen) was used. Test method A Anti-edema effect against carrageenan edema in rat hindlimbs: method of Yamazaki et al. [Japanese Pharmacological Journal Vol. 63, p. 302 (1)
The anti-edema effect was observed according to [967].

被験動物は体重11M±10夕のゥィスター系雄性ラツ
トー群5匹を用いて、起炎剤として、1%カラゲニン溶
液を用いる。被険動物に検体を経口で投与し、1時間後
に起炎剤0.1の‘を片方の後肢足藤皮下に投与する。
趣炎剤投与後1,3,5時間後起炎剤を投与しなかった
対照足と比較して浮腫率を算出する。効果判定は、3時
間目とし対照群と比較して浮腫の抑制率で表わす。その
結果を第1表に示す。B 鎮痛作用 ランドールーセリ
ット法 (Ra地all‐Selit■らの方法(RaMall
,L.0.&Selitb,J.J.アルシーブ・アン
テルナシオール・ドウ・フアルマコデイナミ・エ・ドウ
・テラピー(んch.lnt.P舷rmacodW.)
,111巻、409頁(1957)参照〕に準じて行な
った。
A group of 5 male Wistar rat rats weighing 11M±10cm were used as the test animals, and a 1% carrageenan solution was used as the inflammatory agent. The specimen is orally administered to the animal, and 1 hour later, 0.1% of an inflammatory agent is subcutaneously administered to one hind leg.
The edema rate is calculated 1, 3, and 5 hours after administration of the antiinflammatory agent in comparison with a control foot to which no antiinflammatory agent was administered. The effectiveness was evaluated at 3 hours and expressed as the edema suppression rate compared to the control group. The results are shown in Table 1. B Analgesic effect Randall-Selit method (method of Ra Mall-Selit et al.
,L. 0. &Selitb, J. J. Alceive internationale do pharmacodinami e doe therapy (ch.lnt.p rmacodW.)
, Vol. 111, p. 409 (1957)].

体重110±10夕のウィスター系雄性ラットー群5匹
を用い、ラットの一方の後足艇皮下に糧炎剤として1%
カラゲニン溶液0.1の‘を注射し、3時間後に加圧装
置〔ゥゴバシル社(Ugobasile社)製、イタリ
ー〕で加圧し、泣ら鳥およびもがきを指標に塔痛閥値を
測定した。この時、その闇値が70タ以下の反応性の良
好なラットを選び直ちに検体を経口投与し、以後1,2
,3時間目に炎症足ならびに正常足の疹痛関値を測定し
た。検体を投与しない群群を対照群とする。鎮痛係数は
次式で算出した。結果を第1表に示す。鎮痛係数筋Q 検体投与群の闇値(9)−対照群の闇値側XI。
Using a group of 5 male Wistar rats weighing 110±10 mm, 1% inflammatory agent was administered subcutaneously to one of the rats' hind legs.
A carrageenan solution of 0.1% was injected, and 3 hours later, pressure was applied using a pressure device (manufactured by Ugobasile, Italy), and the pain point value was measured using crying and struggling as indicators. At this time, select a highly responsive rat whose dark value is 70 ta or less, immediately administer the sample orally, and then
After 3 hours, the rash pain level of the inflamed paw and the normal paw was measured. The group to which no specimen is administered will be the control group. The analgesic coefficient was calculated using the following formula. The results are shown in Table 1. Analgesic coefficient muscle Q dark value (9) of sample administration group - dark value side XI of control group.

〇200−対照群の闇値脇)結果 第一表 以上のように本発明で示される化合物は強い消炎、鎮痛
作用を有する。
〇200 - Dark value of control group) Results As shown in Table 1 above, the compound shown in the present invention has strong anti-inflammatory and analgesic effects.

次に本発明の実施例を示すが、本発明はこれによって限
定されるものではない。
Next, examples of the present invention will be shown, but the present invention is not limited thereto.

実施例 1 5−メトキシー3ーメチルー2ーシアノメチルベンゾフ
ラン6.03夕を10%カセイソーダ100の‘で10
独特間加熱還流後、活性炭0.5夕で熱時脱色し、炉過
する。
Example 1 6.03 g of 5-methoxy-3-methyl-2-cyanomethylbenzofuran was dissolved in 100 g of 10% caustic soda.
After heating under reflux for a long time, decolorize with activated carbon for 0.5 hours and filter through a furnace.

炉液を濃塩酸41.5の‘で酸性とし、冷却晶折させる
。結晶を炉別し、50%メタノールで再結晶すると、5
−メトキシ−3−メチル−2ーベンゾフリル酢酸3.7
6夕(収率57%)が得られる。融点 113〜114
00元素分析 C(%)日(%)C,2
日,204としての理論値 65.44 5.49実
測値 65.83 5.72実施例
25−フルオロー3ーメチルー2一アセチルベンゾフ
ラン8.3夕、硫黄1.92夕および無水モルホリン5
.6夕を15時間還流温度に加熱する。
The furnace liquid was made acidic with 41.5 g of concentrated hydrochloric acid and crystallized on cooling. When the crystals are separated in a furnace and recrystallized with 50% methanol, 5
-Methoxy-3-methyl-2-benzofuryl acetic acid 3.7
6 days (yield 57%) is obtained. Melting point 113-114
00 elemental analysis C (%) day (%) C,2
Theoretical value as day, 204 65.44 5.49 Actual value 65.83 5.72 Example 25-fluoro-3-methyl-2-acetylbenzofuran 8.3 hours, sulfur 1.92 hours and anhydrous morpholine 5
.. Heat to reflux temperature for 6 hours for 15 hours.

反応後、反応液を減圧濃縮しした残経に水20私を加え
ると結晶が析出する。これを炉取し、酢酸20の‘と濃
硫酸3.6の‘および水5.3の‘と共に6時間煮沸し
て加水分解する。この溶液を冷却後炭酸ソーダで中和し
、ベンゼンで洗浄する。水層を塩酸で酸性にして目的の
酸を遊離させ、酢酸エチルで抽出し、酢酸エチル層を葦
硝で脱水後濃縮し、残糟を85%メタ/ールから再結晶
すると、5−フルオロ−3ーメチル−2ーベンゾフリル
酢酸5.1夕が得られる。収率 56.2% 融点 129〜13ぴ0 元素分析 C(%)日(%)F(%) C,.日903Fとしての理論値 63.464.
369.13実測値 63.磯
4.229.20実施例 3容量500肌‘の5つ口フ
ラスコに気密の蝿梓装置、還流冷却器、滴下ロートおよ
び窒素ガス導入管、温度計を取りつけ、器内を塩化カル
シウム管によって外気の湿度から遮断する。
After the reaction, the reaction solution was concentrated under reduced pressure and 20 ml of water was added to the residue to precipitate crystals. This is taken in a furnace and boiled for 6 hours with 20 parts of acetic acid, 3.6 parts of concentrated sulfuric acid, and 5.3 parts of water to hydrolyze it. After cooling, the solution is neutralized with sodium carbonate and washed with benzene. The aqueous layer was acidified with hydrochloric acid to liberate the desired acid, extracted with ethyl acetate, the ethyl acetate layer was dehydrated with reed sulfur, concentrated, and the residue was recrystallized from 85% methanol. 5.1 portions of -3-methyl-2-benzofuryl acetic acid are obtained. Yield 56.2% Melting point 129-13pp0 Elemental analysis C (%) day (%) F (%) C,. Theoretical value as day 903F 63.464.
369.13 Actual value 63. Iso 4.229.20 Example 3 A 5-necked flask with a capacity of 500 cm was equipped with an airtight flywheel device, a reflux condenser, a dropping funnel, a nitrogen gas introduction tube, and a thermometer, and the inside of the flask was connected to outside air through a calcium chloride tube. Insulate from humidity.

このフラスコ内に粉末状マグネシウム2.55夕をおよ
び無水エーテル20机とヨウ素結晶数個を入れ窒素ガス
を導入する。次にこれをかきまぜ、5ーフェニルー3ー
メチルー2−クロロメチルベンゾフラン25.7夕を無
水エーテル80奴に溶解した溶液を0.5肌と滴下する
。反応が開始したら、エーテルが還流するような速度で
残りの6−フェニル−3−メチル−2−クロロメチルベ
ンゾフランのエーテル溶液を滴下しつつ反応を行なう。
滴下終了後さらに15分間かきまぜ還流させる。その後
滴下ロート、窒素ガス導入管をとりはずし、炭酸ガス導
入管を取りつけ反応液を−5℃に冷却する。温度を−6
℃に保ちつつかきまぜながら塩化カルシウムで乾燥した
炭酸ガスを約5時間導入する。炭酸ガス導入後、希硫酸
(2.州硫酸100の‘十水100叫)とエーテル20
0私を加え、分液ロートに移し分液する。エーテル層を
水洗した後10%カセイソーダ水溶液200の上で抽出
しエーテルで洗浄した後、さらに2.則塩酸で酸性にし
エーテル200の【で抽出を2回行ない、エーテル層を
き硝で乾燥し、エーテルを留去濃縮し、残燈を85%メ
タノルで再結晶すると5ーフェニルー3ーメチルー2ー
ベンゾフリル酢酸19.1夕(収率72%)を得る。融
点 173〜17400 元素分析 C(%)日(%) C,7日,403としての理論値 76.斑 5.
30実測値 76.84 5.34実施例 4 5‐ペンジル−3ーメチルー2−ペンゾフロイルクロラ
イド9.96夕をテトラヒドロフラン350の【に溶解
し、冷却却蝿梓下にこれをジアゾメタンのエーテル溶液
30の【中に約0時間かけて滴下しした。
Into this flask were placed 2.55 kg of powdered magnesium, 20 kg of anhydrous ether, and several iodine crystals, and nitrogen gas was introduced. Next, stir this and drop 0.5 parts of a solution prepared by dissolving 25.7 parts of 5-phenyl-3-methyl-2-chloromethylbenzofuran in 80 parts of anhydrous ether. Once the reaction has started, the remaining ether solution of 6-phenyl-3-methyl-2-chloromethylbenzofuran is added dropwise at such a rate that the ether is refluxed.
After the addition is complete, stir and reflux for an additional 15 minutes. Thereafter, the dropping funnel and nitrogen gas introduction tube were removed, a carbon dioxide gas introduction tube was attached, and the reaction solution was cooled to -5°C. Temperature -6
Carbon dioxide gas dried with calcium chloride is introduced for about 5 hours while stirring and maintaining the temperature at ℃. After introducing carbon dioxide gas, add dilute sulfuric acid (2. 100% sulfuric acid to 100% sulfuric acid) and 20% ether.
Add 0 I, transfer to a separating funnel and separate the liquids. The ether layer was washed with water, extracted with 200% 10% caustic soda aqueous solution, washed with ether, and further extracted with 2. The ether layer was acidified with hydrochloric acid and extracted twice with 200% of ether. The ether layer was dried with sulfuric acid, the ether was distilled off, and the residual light was recrystallized with 85% methanol to give 5-phenyl-3-methyl-2-benzofuryl acetic acid. One day (yield 72%) was obtained. Melting point 173-17400 Elemental analysis C (%) days (%) C, 7 days, theoretical value as 403 76. Spots 5.
30 Actual value 76.84 5.34 Example 4 5-penzyl-3-methyl-2-penzofuroyl chloride (9.96 g) was dissolved in 350 g of tetrahydrofuran, and this was dissolved in an ether solution of diazomethane (30 g. It took about 0 hours to drip into the inside of the bottle.

この反応液をさらに3時間室温でかさまぜた後、減圧濃
縮する。この濃縮残澄をジオキサン80舷に溶解して、
酸化銀8.2夕、五水和チオ硫酸ナトリウム22夕、水
430の‘の懸濁液に60〜7ぴ0に保ちながら1時間
かけて滴下かきまぜた。この反応液を更に1時間60〜
7ぴ0でかきまぜた後、活性炭を加えて脱色炉過し、炉
液を40%酢酸で酸性にして析出した結晶を炉取した。
これを85%のメタノールで再結晶して5ーベンジルー
3ーメチルー2ーベンゾフリル酢酸5.4夕を得た。収
率 55%融点
149〜15000元素分析
O C(%)日(%)C,8日,
603としての理論値 77.12 5.75実測値
77.38 5.70実施例 5 4一〔(5一tーブチル−3ーメチルー2ーベタンゾフ
リル)メチル〕−6ーフエニル−2H−1,3,6−オ
キサジアジン−2ーオン3.7夕を酢酸40舷、州塩酸
4の‘の混合液に加え、無色になるまで約5時間還流す
る。
The reaction solution was further stirred at room temperature for 3 hours, and then concentrated under reduced pressure. This concentrated residue was dissolved in dioxane 80 mm,
The mixture was added dropwise to a suspension of 8.2 parts silver oxide, 22 parts sodium thiosulfate pentahydrate, and 430 parts water and stirred over 1 hour while maintaining the temperature at 60 to 7 parts. This reaction solution was heated for another 1 hour at 60~
After stirring at 70°C, activated carbon was added and the mixture was passed through a decolorizing oven. The solution was acidified with 40% acetic acid and the precipitated crystals were collected using the oven.
This was recrystallized from 85% methanol to obtain 5.4% of 5-benzyl-3-methyl-2-benzofuryl acetic acid. Yield 55% Melting point
149-15000 elemental analysis OC (%) day (%) C, 8 days,
Theoretical value as 603 77.12 5.75 Actual value 77.38 5.70 Example 5 4-[(5-t-butyl-3-methyl-2-betanzofuryl)methyl]-6-phenyl-2H-1,3,6- Add 3.7 hours of oxadiazin-2-one to a mixture of 40 degrees of acetic acid and 4 hours of hydrochloric acid, and reflux for about 5 hours until it becomes colorless.

反応後、濃縮冷却すると、結晶が析出する。結晶を炉別
し、ベンゼン0で再結晶すると、5−tープチル−3一
メチルーベンゾフリル酢酸1.5夕が得られる。収率
67.6% 融点 169〜170q○ 元素分析 C(%)日(%) C,虹,803としての理論値 73.14 7.3
7実測値 73.01 7.44実施例 6 10夕の5一sec−ブチルー3ーメチルー2−シアノ
メチルベンゾフランを用いて実施例1と同様の方法によ
って反応後、濃塩酸43の【で酸性とし得られる5一s
ec−ブチルー3ーメチルー2ーベンゾフリル酢酸の粗
結晶をシクロヘキサノンから再結晶すると、精製5一s
ecーブチルー3ーメチルー2−ペンゾフリル酢酸7.
6夕(収率70.4%)が得られる。
After the reaction, the mixture is concentrated and cooled to precipitate crystals. The crystals are separated by furnace and recrystallized with 0% benzene to obtain 1.5% 5-tert-butyl-3-methyl-benzofuryl acetic acid. yield
67.6% Melting point 169-170q○ Elemental analysis C (%) Day (%) Theoretical value as C, Rainbow, 803 73.14 7.3
7 Actual value 73.01 7.44 Example 6 After reacting in the same manner as in Example 1 using 51 sec-butyl-3-methyl-2-cyanomethylbenzofuran for 10 min, it was made acidic with 43 ml of concentrated hydrochloric acid. 51s
When the crude crystals of ec-butyl-3-methyl-2-benzofuryl acetic acid are recrystallized from cyclohexanone, purified 5-s
ec-butyl-3-methyl-2-penzofuryl acetic acid7.
6 days (yield 70.4%) is obtained.

鷲虫点 127〜129q○ 元素分析 C(%)日(%) C,幻,803としての理論値 73.14 7.3
7実測値 73.21 7.62実施例 7 5一n−へキシルー3−メチル−2−アセチルベンゾフ
ラン11.0夕を用いて実施例2と同様の方法によって
5一nーヘキシルー3ーメチルー2ーベンゾフリル酢酸
の粗結晶が得られる。
Washimushi point 127-129q○ Elemental analysis C (%) Day (%) Theoretical value as C, illusion, 803 73.14 7.3
7 Actual value 73.21 7.62 Example 7 51 n-hexy-3-methyl-2-benzofuryl acetic acid was prepared in the same manner as in Example 2 using 11.0 ml of 51 n-hexy-3-methyl-2-acetylbenzofuran. Crude crystals are obtained.

メタノ−ルから再結晶して精製5一nーヘキシルー3−
メチル−2−ペンゾフリル酢酸5.7夕(収率48.7
%)が得られる。融点 175〜700 元素分析 C(%)日(%) C,7日2。
Purified by recrystallization from methanol 51n-hexyl3-
Methyl-2-penzofuryl acetic acid 5.7 hours (yield 48.7
%) is obtained. Melting point 175-700 Elemental analysis C (%) days (%) C, 7 days 2.

Claims (1)

【特許請求の範囲】 1 一般式〔I〕 ▲数式、化学式、表等があります▼ 〔但し、式中R_1はC_2〜C_6のアルキル基、
C_1〜C_6のアルコキシ基、フエニル基、弗素原子
又はベンジル基を表す〕で表される5−置換−3−メチ
ル−2−ベンゾフリル酢酸およびその薬理的に無毒な塩
[Claims] 1 General formula [I] ▲There are mathematical formulas, chemical formulas, tables, etc.▼ [However, in the formula, R_1 is an alkyl group of C_2 to C_6,
5-substituted-3-methyl-2-benzofuryl acetic acid represented by C_1 to C_6 alkoxy group, phenyl group, fluorine atom or benzyl group] and pharmacologically non-toxic salts thereof.
JP13876A 1976-01-01 1976-01-01 Novel benzofuran derivative Expired JPS6018659B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP13876A JPS6018659B2 (en) 1976-01-01 1976-01-01 Novel benzofuran derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13876A JPS6018659B2 (en) 1976-01-01 1976-01-01 Novel benzofuran derivative

Publications (2)

Publication Number Publication Date
JPS5283543A JPS5283543A (en) 1977-07-12
JPS6018659B2 true JPS6018659B2 (en) 1985-05-11

Family

ID=11465656

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13876A Expired JPS6018659B2 (en) 1976-01-01 1976-01-01 Novel benzofuran derivative

Country Status (1)

Country Link
JP (1) JPS6018659B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1030851B1 (en) * 1997-11-12 2005-01-12 Darwin Discovery Limited Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity

Also Published As

Publication number Publication date
JPS5283543A (en) 1977-07-12

Similar Documents

Publication Publication Date Title
US4070539A (en) [1-Oxo-2-halo(or hydrogen) indanyloxy]-alkanoic acid
US3484445A (en) Derivatives of chromone-2-carboxylic acid
EP0257882B1 (en) N-phenyl butenamides with pharmaceutical properties
JPS582936B2 (en) 5↓-Production method of aroylpyrroleacetic acid and its salts
EP0094102B1 (en) 1-(1-cyclohexanyl-methyl) pyrrolidine derivatives, and process for their preparation
EP0074170B1 (en) Chroman compounds, process for producing them and pharmaceutical compositions containing them
JPH0222059B2 (en)
US3255242A (en) (alpha-alkylideneacyl)naphthyloxy monocarboxylic acids
Holmes et al. The chemistry of heterocyclic quinones. I. the direct oxidation of 6-hydroxycarbostyrils to carbostyril-5, 6-quinones
US4473583A (en) Compositions containing certain derivatives of 4-phenyl-4-oxobuten-2-oic acid and methods of treatment using them
JPS6018659B2 (en) Novel benzofuran derivative
JPH07119188B2 (en) Chalcone derivative
JPH0559117B2 (en)
EP0132124A1 (en) Novel pharmaceutical compounds and their preparation
PT85477B (en) PROCESS FOR THE PREPARATION OF PHENYL BUTENAMIDE SUBSTITUTED HETEROCYCLIC DERIVATIVES
US3847994A (en) 2,2-dimethyl-5-(aryloxy)-valeraldehydes
JPH0710863B2 (en) Novel derivative of 4-OH quinolinecarboxylic acid substituted at position 2 with an etherifiable or esterifiable dihydroxy group, a process for its preparation and its use as a medicament
US3105090A (en) Derivatives of alkyl benzoic acid and salts thereof with bases
JPS6353984B2 (en)
US4562287A (en) 2-(4-Biphenylyl)-4-hexenoic acid and derivatives thereof having anti-inflammatory activity
US4247715A (en) 2-Alkynyl-5-indanyloxyacetic acids
US4302463A (en) 1-Azaxanthone-3-carboxylic acids and their production
JPS6041059B2 (en) Novel phenylpropionate derivative
Kirkpatrick et al. Dibenzofuran. VI. Amino Derivatives
JPS6045172B2 (en) chalcone derivative